Potent antagonists for the human adenosine A2B receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity
- 1 November 1999
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 48 (3), 95-103
- https://doi.org/10.1002/(sici)1098-2299(199911)48:3<95::aid-ddr1>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- 1,3-dialkylxanthine derivatives having high potency as antagonists at human A2B adenosine receptorsDrug Development Research, 1999
- A Functional Screening of Adenosine Analogues at the Adenosine A2BReceptor: A Search for Potent AgonistsNucleosides and Nucleotides, 1998
- Adenosine A2B receptors: a novel therapeutic target in asthma?Trends in Pharmacological Sciences, 1998
- Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cellsBritish Journal of Pharmacology, 1996
- Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptorsDrug Development Research, 1996
- The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonistBritish Journal of Pharmacology, 1995
- Adenine isosteres with bridgehead nitrogen. Part 1. Two independent syntheses of the [1,2,4]triazolo[1,5-a][1,3,5]triazine ring system leading to a range of substituents in the 2, 5 and 7 positionsJournal of the Chemical Society, Perkin Transactions 1, 1995
- Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblastsBiochemical Pharmacology, 1994
- Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonistsJournal of Medicinal Chemistry, 1988
- Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthinesCellular and Molecular Neurobiology, 1983